Advanced Solid Tumors

86 total trials 40 recruiting

Filter these 86 trials by phase, country, sponsor and more.

Open in Search →

Study of safety and antitumor activity of GEN1056 in participants with advanced solid tumors Ended

2024-514357-29-00 1 2022-11-04
A study in patients with different types of advanced cancer (solid tumors) to test different doses of BI 907828 (brigimadlin) in combination … Ended

2024-511352-41-00 3 2022-06-13
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors Ended

2024-511286-11-00 1 2022-06-03
Phase IB Study to Assess the Safety, Tolerability and Efficacy of PM14 in combination with Atezolizumab in Pretreated Patients with Selected … Ended

2023-509688-25-00 3 2021-11-23
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended

2023-510511-19-00 7 2021-11-08
7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors Ended

2023-505284-36-00 4 2021-09-13
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan … Ended

2024-512227-36-00 9 2021-07-28
A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) Ended

2022-500821-34-00 1 2021-06-15
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986253 Given in Combination with Nivolumab or Nivolumab plus Ipilimum … Ended

2023-509061-20-00 9 2018-11-22
Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM14 Administered Intravenously to Patients with Advanced Solid … Ended

2024-511916-25-00 7 2017-09-04
A phase I dose finding study of oral TNO155 in adult patients with advanced solid tumors Ended

2023-508925-29-00 1 2017-06-29
A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors Ended

2022-502622-40-00 1
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors. Ended

2023-506661-65-00 3
First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors Ended

2024-517984-21-00 1

Showing 73–86 of 86 trials